HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiyuki Hattori Selected Research

didodecyldimethylammonium

8/2022Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes.
1/2015siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiyuki Hattori Research Topics

Disease

45Neoplasms (Cancer)
04/2019 - 03/2005
11Carcinoma (Carcinomatosis)
11/2017 - 05/2006
7Breast Neoplasms (Breast Cancer)
08/2022 - 11/2009
6Neoplasm Metastasis (Metastasis)
01/2019 - 12/2014
6Prostatic Neoplasms (Prostate Cancer)
11/2009 - 05/2004
5Inflammation (Inflammations)
01/2021 - 06/2006
5Ischemia
07/2003 - 02/2000
4Type 2 Diabetes Mellitus (MODY)
01/2020 - 09/2010
4Hypertension (High Blood Pressure)
01/2011 - 07/2005
4Atherosclerosis
09/2009 - 11/2002
4Necrosis
01/2009 - 07/2002
3Dehydration (Water Stress)
10/2021 - 02/2009
3Insulin Resistance
01/2020 - 12/2004
3Lewis Lung Carcinoma
09/2017 - 07/2015
3Myocardial Ischemia (Ischemic Heart Diseases)
10/2011 - 07/2002
3Body Weight (Weight, Body)
05/2008 - 02/2006
3Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
07/2007 - 10/2005
3Hypoadiponectinemia
02/2007 - 04/2005
3Reperfusion Injury
07/2003 - 07/2002
2Arthritis (Polyarthritis)
12/2021 - 01/2021
2Fibrosis (Cirrhosis)
01/2021 - 04/2009
2Ulcerative Colitis
03/2020 - 01/2019
2Colitis
07/2019 - 01/2019
2Neuroblastoma
06/2013 - 09/2010
2Diabetes Mellitus
10/2011 - 07/2009
2Stroke (Strokes)
10/2011 - 07/2009
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2011 - 04/2005
2Asthma (Bronchial Asthma)
05/2010 - 05/2009
2Vascular Diseases (Vascular Disease)
02/2008 - 04/2007
2Hepatoblastoma
11/2007 - 03/2005
2Hypertrophy
02/2006 - 07/2005
2Hyperthyroidism
01/2006 - 01/2006

Drug/Important Bio-Agent (IBA)

18Liposomes (Liposome)IBA
08/2022 - 07/2005
18Small Interfering RNA (siRNA)IBA
08/2022 - 06/2006
17DNA (Deoxyribonucleic Acid)IBA
08/2013 - 05/2004
16LipidsIBA
08/2022 - 07/2005
12Folic Acid (Vitamin M)FDA LinkGeneric
04/2019 - 05/2004
10Messenger RNA (mRNA)IBA
11/2017 - 07/2006
9CholesterolIBA
12/2017 - 05/2006
8hydroxide ionIBA
12/2017 - 07/2007
7Pharmaceutical PreparationsIBA
12/2021 - 07/2005
7Polysorbates (PSML)FDA Link
01/2015 - 07/2007
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2015 - 09/2002
6NF-kappa B (NF-kB)IBA
05/2010 - 07/2002
6Proteins (Proteins, Gene)FDA Link
09/2009 - 02/2000
6AdiponectinIBA
09/2009 - 04/2005
5LuciferasesIBA
08/2022 - 08/2006
5CytokinesIBA
01/2020 - 07/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
11/2017 - 07/2012
4SolutionsIBA
07/2015 - 07/2007
3Prednisolone (Predate)FDA LinkGeneric
12/2021 - 01/2019
3Sulfonic AcidsIBA
03/2020 - 01/2019
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
04/2019 - 12/2008
3Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2019 - 08/2013
3protein kinase NIBA
01/2019 - 01/2016
3Therapeutic UsesIBA
11/2017 - 04/2010
3Glutamic Acid (Glutamate)FDA Link
06/2017 - 08/2013
3liposomal doxorubicin (Doxil)FDA Link
06/2017 - 01/2011
3Prostaglandins AIBA
06/2017 - 12/2014
3PolymersIBA
01/2016 - 03/2007
3DiaminesIBA
01/2015 - 01/2013
3CollagenIBA
02/2012 - 03/2007
3Histone Deacetylase InhibitorsIBA
01/2011 - 06/2007
3PPAR gammaIBA
09/2009 - 07/2002
3LigandsIBA
12/2008 - 07/2002
3PPAR alphaIBA
04/2008 - 07/2002
3Thymidine KinaseIBA
07/2007 - 10/2005
3Connexin 43 (Connexin43)IBA
06/2007 - 10/2005
3sapropterin (tetrahydrobiopterin)FDA Link
04/2007 - 02/2000
3Pioglitazone (Actos)FDA Link
10/2006 - 07/2002
21,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
08/2022 - 01/2015
2didodecyldimethylammoniumIBA
08/2022 - 01/2015
2polyethylene glycol polyethyleneimine nanogelIBA
01/2021 - 01/2019
2Polo-Like Kinase 1IBA
04/2019 - 11/2017
2Zoledronic Acid (Zometa)FDA Link
07/2015 - 01/2015
2N- (2- (2- (2- hydroxyethylamino)ethylamino)ethyl)cholesteryl- 3- carboxamideIBA
02/2013 - 01/2013
2Tumor Viral Antigens (Large T Antigen)IBA
07/2012 - 09/2010
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2011 - 09/2010
2VitaminsIBA
07/2010 - 07/2005
2Irinotecan (Camptosar)FDA LinkGeneric
04/2010 - 05/2009
2Drug CarriersIBA
06/2008 - 03/2005
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2008 - 05/2008
2Ganciclovir (Cytovene)FDA LinkGeneric
07/2007 - 01/2006
2Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2007 - 04/2005
2Nitric Oxide Synthase (NO Synthase)IBA
01/2007 - 02/2000
2Bleomycin (Blenoxane)FDA LinkGeneric
06/2006 - 08/2005
2AICA ribonucleotide (ZMP)IBA
06/2006 - 02/2006
2Acetylcholine (Acetylcholine Chloride)FDA Link
07/2005 - 02/2000
2Peroxynitrous Acid (Peroxynitrite)IBA
07/2005 - 07/2002
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2003 - 07/2002
2ClofibrateFDA Link
12/2002 - 07/2002
2salicylhydroxamic acid (SHAM)IBA
09/2002 - 02/2000
1Phospholipids (Phosphatides)FDA LinkGeneric
08/2022
1phosphatidylethanolamineIBA
08/2022
1NitrogenIBA
10/2021
1AlginatesIBA
01/2021
1Histone Deacetylases (Histone Deacetylase)IBA
01/2021

Therapy/Procedure

10Therapeutics
03/2020 - 07/2002
8Intravenous Injections
01/2016 - 01/2007
4Injections
01/2016 - 12/2014